Skip to main content

Vol. 2026 · Bill Detail · Special Edition

CivicRadar.

Wednesday, September 2, 2026

Free · Stays on your device

KS · SB212CMTE · 1 COSPONSOR

Enacting the prescription drug cost and affordability review act to establish the prescription drug pricing board and prescription drug affordability stakeholder council to review the cost of prescription medications and establish upper payment limits for certain prescription drugs.

Also relevant to:Senior (65+, Medicare/SS)
Where it is in the process
Plain-English Summary

This bill establishes the Prescription Drug Cost and Affordability Review Act in Kansas. It creates a Prescription Drug Affordability Board and a stakeholder council to review the costs of certain prescription drugs. If the board finds that a drug's cost creates affordability challenges, it can set an upper payment limit for that drug.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text

Votes
Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when KS SB212 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

  • RSS feed· Atom 1.0 + JSON Feed per bill
  • Bluesky· follow a CivicRadar bot post per status change
  • Telegram· channel or DM via bot
  • Discord· channel webhook
  • WhatsApp· via WhatsApp Business
  • SMS· via Twilio